| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |